116 related articles for article (PubMed ID: 31901328)
1. Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?
Bayraktar A; Akgül SU; Bakkaloğlu H; Temurhan S; Çınar ÇK; Çiftçi HŞ; Kaan Gök AF; Demir E; Oğuz FS; Türkmen A
Transplant Proc; 2020; 52(1):97-101. PubMed ID: 31901328
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition.
Crespo G; Trota N; Londoño MC; Mauro E; Baliellas C; Castells L; Castellote J; Tort J; Forns X; Navasa M
J Hepatol; 2018 Jul; 69(1):11-17. PubMed ID: 29481821
[TBL] [Abstract][Full Text] [Related]
3. Clearance and persistence of hepatitis C virus in a Tunisian population: association with HLA class I and class II.
Ksiaa L; Ayed-Jendoubi S; Sfar I; Gorgi Y; Najjar HA; Abdallah TB; Ayed K
Viral Immunol; 2007; 20(2):312-9. PubMed ID: 17603847
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
Bhamidimarri KR; Ladino M; Pedraza F; Guerra G; Mattiazzi A; Chen L; Ciancio G; Kupin W; Martin P; Burke G; Roth D
Transpl Int; 2017 Sep; 30(9):865-873. PubMed ID: 28332729
[TBL] [Abstract][Full Text] [Related]
5. HLA-E*01:01 allele is associated with better response to anti-HCV therapy while homozygous status for HLA-E*01:03 allele increases the resistance to anti-HCV treatments in frequently transfused thalassemia patients.
Hosseini E; Sarraf Kazerooni E; Azarkeivan A; Sharifi Z; Shahabi M; Ghasemzadeh M
Hum Immunol; 2022 Jul; 83(7):556-563. PubMed ID: 35570067
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment.
Romano C; Tortorella O; Dalla Mora L; Di Stasio D; Sellitto A; Adinolfi LE; Marrone A
Front Immunol; 2022; 13():882064. PubMed ID: 35479086
[TBL] [Abstract][Full Text] [Related]
7. HLA-G and anti-HCV in patients on the waiting list for kidney transplantation.
Sommese L; Paolillo R; Cacciatore F; Grimaldi V; Sabia C; Esposito A; Sorriento A; Iannone C; Rupealta N; Sarno G; Santangelo M; De Rosa P; Nicoletti G; Napoli C
Adv Med Sci; 2018 Sep; 63(2):317-322. PubMed ID: 30015095
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct-acting antivirals: The role of prior treatment with interferon plus ribavirin.
Alsius M; Ferri MJ; Buxó M; López C; Serra I; Queralt X; Acero D
Gastroenterol Hepatol; 2019 Feb; 42(2):82-89. PubMed ID: 30446175
[TBL] [Abstract][Full Text] [Related]
10. The role of anti-HBs in hepatitis B reactivation during direct-acting antiviral therapy for chronic hepatitis C.
Spaan M; Bruce M; Agarwal K; Carey I
Antivir Ther; 2018; 23(6):539-542. PubMed ID: 30309997
[TBL] [Abstract][Full Text] [Related]
11. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia.
Cramp ME; Carucci P; Underhill J; Naoumov NV; Williams R; Donaldson PT
J Hepatol; 1998 Aug; 29(2):207-13. PubMed ID: 9722201
[TBL] [Abstract][Full Text] [Related]
12. Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.
Kuniholm MH; Kovacs A; Gao X; Xue X; Marti D; Thio CL; Peters MG; Terrault NA; Greenblatt RM; Goedert JJ; Cohen MH; Minkoff H; Gange SJ; Anastos K; Fazzari M; Harris TG; Young MA; Strickler HD; Carrington M
Hepatology; 2010 May; 51(5):1514-22. PubMed ID: 20169624
[TBL] [Abstract][Full Text] [Related]
13. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.
Urbani S; Amadei B; Tola D; Pedrazzi G; Sacchelli L; Cavallo MC; Orlandini A; Missale G; Ferrari C
J Hepatol; 2008 Apr; 48(4):548-58. PubMed ID: 18280607
[TBL] [Abstract][Full Text] [Related]
14. Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.
Iversen J; Dore GJ; Catlett B; Cunningham P; Grebely J; Maher L
J Hepatol; 2019 Jan; 70(1):33-39. PubMed ID: 30367897
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
16. Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct-acting antiviral therapies in the United States.
Young K; Liu B; Bhuket T; Gish RG; Wong RJ
J Viral Hepat; 2019 Mar; 26(3):350-361. PubMed ID: 30412318
[TBL] [Abstract][Full Text] [Related]
17. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
18. Selection and management of hepatitis C virus-infected patients for the kidney transplant waiting list.
Roth D; Bloom R
Contrib Nephrol; 2012; 176():66-76. PubMed ID: 22310782
[TBL] [Abstract][Full Text] [Related]
19. Impact of hepatitis C virus and direct acting antivirals on kidney recipients: a retrospective study.
Gendia M; Lampertico P; Alfieri CM; D'Ambrosio R; Gandolfo MT; Campise MR; Fabrizi F; Messa P
Transpl Int; 2019 May; 32(5):493-501. PubMed ID: 30580473
[TBL] [Abstract][Full Text] [Related]
20. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
